Cortexyme Announces Presentation of Data Revealing Link Between Bacterial Pathogen and Genetic Risk for Alzheimer?s Disease

San Diego Biotechnology Network
San Diego Biotechnology Network
Cortexyme Announces Presentation of Data Revealing Link Between Bacterial Pathogen and Genetic Risk for Alzheimer?s Disease
Loading
/

SAN DIEGO & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX) today announced the presentation of new data supporting the on-target activity of COR388, its lead investigational medicine, and linking the ?gingipain hypothesis? for Alzheimer?s disease (AD) to the significance of the APOE gene as a major risk factor for the disease. Michael Detke, M.D., Ph.D., the company?s chief medical officer, detailed the results in an oral presentation (abstract #OC28) at the 2019 C


ADVERTISEMENT — Advertise With Biotech Networks